# The Effect of Saxagliptin on Glucose Fluctuation and Immune Regulation in Patients With Type 1 Diabetes

> **NCT02307695** · PHASE4 · UNKNOWN · sponsor: **Nanjing Medical University** · enrollment: 184 (estimated)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Saxagliptin
- **DRUG:** Insulin

## Key facts

- **NCT ID:** NCT02307695
- **Lead sponsor:** Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-11
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 184 (ESTIMATED)
- **Last updated:** 2016-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02307695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02307695, "The Effect of Saxagliptin on Glucose Fluctuation and Immune Regulation in Patients With Type 1 Diabetes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02307695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*